Text Size

The Value of Preoperative Dynamic Lymphscintigraphy and Ultrasoundscanning, Eventually With FNA, for Identification of Malignant Sentinel Node(s) in Patients With Melanoma

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Trine-Lise Lambine, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT01677975
First received: August 30, 2012
Last updated: August 31, 2012
Last verified: August 2012
History of Changes
  Purpose

The goal with this study is to evaluate the value of dynamic lymphscintigraphy and ultrasoundscanning preoperative in patients with melanomas.


Condition Intervention
Melanoma
 Procedure: FNA (fine needle aspiration)

Study Type: Interventional

Resource links provided by NLM:

MedlinePlus related topics: Melanoma
U.S. FDA Resources

Further study details as provided by Rigshospitalet, Denmark:

Study Start Date: September 2012
Arms Assigned Interventions
Experimental: ultrasound, dynamic lymphscintigraphy Procedure: FNA (fine needle aspiration)

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Histologically verified melanomas, at least 1 mm thickness, or thinner melanomas with ulceration and/or Clarks level IV-V and/or mitoserate at least 1/mm2.

Exclusion Criteria:

Other malignant illness Known local, regional or non-regional metastasis on the time of diagnonsis Comorbidity which contraindicate lymphnoderemoval Age less than 18 yrs

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01677975

Locations
Denmark
Ultrasounddepartment 4123, Rigshospitalet
Blegdamsvej 9, København Ø, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark
  More Information

No publications provided

Responsible Party: Trine-Lise Lambine, afdelingslæge, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier: NCT01677975     History of Changes
Other Study ID Numbers: Ultrasound in melanomas
Study First Received: August 30, 2012
Last Updated: August 31, 2012
Health Authority: Denmark: Rigshospitalet
Denmark: The Danish Scientific Ethical Committee (De Videnskabsetiske Komiteer for Region Hovedstaden)

Additional relevant MeSH terms:
Melanoma
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
 Neoplasms by Histologic Type
Neoplasms
Neoplasms, Nerve Tissue
Nevi and Melanomas

ClinicalTrials.gov processed this record on May 21, 2013